Skip to main content
Journal of Genetic Engineering and Biotechnology
Fig. 5 | Journal of Genetic Engineering and Biotechnology

Fig. 5

From: Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery

Fig. 5

a The result of western blotting for recombinant expressed VP2, Lane 1: The VP2 band (~64 kDa) confirmed by using a specific mouse monoclonal antibody against this protein, Lane 2: The negative control (BSA), Lane 3: Prestained protein ladder (MyBioSource, USA). b The protein fraction resulting from the accumulation of intended VLP nanoparticles in tubes 1 and 2 containing discontinuous cesium chloride gradient after ultracentrifugation. c SDS-PAGE result of the purified VLPs, Lane 1: Molecular weight marker (Sinaclon, Iran), Lanes 2 and 3: The expected protein band (~64 kDa) related to VP2 subunits resulting from disassembly of the purified VLPs

Back to article page